ArticleJournal of diabetes investigation2026
Improved prognosis prediction of all-cause mortality and cardiovascular events by combined assessment of both ankle-brachial index and brachial-ankle pulse wave velocity in individuals with diabetes: The Kyushu prevention study for atherosclerosis, a prospective, multicenter survey.
Article in Journal of diabetes investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Relevance and Potential Applications of Brachial-Ankle Pulse Wave Velocity: Current Evidence and Future Perspectives.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
AIMS/
introductionPeople with diabetes exhibit early-stage cardiovascular disease (CVD). In this study, we developed a new diagnostic algorithm to predict all-cause mortality and CVD using both the ankle-brachial index (ABI) and brachial-ankle pulse wave velocity (baPWV) in individuals with diabetes. MATERIALS AND
methodsThis study utilized data from the Kyushu Prevention Study for Atherosclerosis, a prospective, multicenter survey. A total of 3,933 participants with diabetes were followed. The primary outcomes were all-cause mortality and CVD. Risk was categorized based on ABI and baPWV, and the prognostic differences were evaluated. Additionally, the independence of this classification from the Framingham Risk Score (FRS) was tested.
resultsABI was the strongest predictor of all-cause mortality. Individuals with a low ABI (<0.70) had the highest risk, while those with an intermediate ABI (0.70-1.0) exhibited a risk similar to individuals with the extremely high baPWV (≥24 m/s), forming the second highest-risk group. For coronary heart disease, ABI and baPWV had complementary predictive value. Individuals with a low ABI (<1.0) or high baPWV (≥19 m/s) were at the highest risk, whereas those with a low baPWV (<14 m/s) had the lowest risk. For cerebrovascular disease, only baPWV was a significant predictor, with risk cutoffs above 23 m/s and below 14 m/s.
conclusionsWe developed a new diagnostic algorithm incorporating both ABI and baPWV to predict all-cause mortality and CVD in individuals with diabetes. This algorithm improved the accuracy of mortality and CVD risk assessment and was independent from the FRS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.